Nicolò Matteo Luca Battisti, Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, shared a post on LinkedIn by Abu Saleh Md Taher, Medical Oncology Specialty Registrar (ST5) at The Royal Marsden Hospital, adding:
“Please check out this very insightful review authored by our brilliant MD(Res) fellow Dr Abu Saleh Md Taher and Senior Adult Oncology Programme Pharmacist Vanya Slavova-Boneva at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research.
This review highlights a critical and often under-recognised challenge in oncology: the complexity of managing polypharmacy in older adults with cancer, and its impact on treatment outcomes, toxicity, and quality of life.
It also outlines practical strategies to optimise medicines and improve adherence: key components of delivering truly personalised, high-quality cancer care for older adults.”
Quoting Abu Saleh Md Taher’s post:
“Older adults with cancer often take ≥5–10 medications-yet polypharmacy remains under-recognised as a driver of toxicity, drug interactions, and poor adherence.
Our recent review in Current Oncology Reports outlines practical strategies, including medication optimisation, geriatric assessment, and the emerging role of digital and AI tools.
Grateful to Nicolò Matteo Luca Battisti for guidance and support.”
Title: Polypharmacy, Medicine Optimisation, and Medication Adherence in Older Cancer Patients
Authors: Abu Saleh Md Taher, Vanya Slavova-Boneva, Nicolò Matteo Luca Battisti
Read The Full Article
Other articles featuring Nicolò Matteo Luca Battisti on OncoDaily.